Press release
Next Generation Antibody Therapeutics Market Witnessing a Robust CAGR of 21.5%, To Reach US$ 39450 Million During The Forecast Period 2024-2030 | The Market Reports
Antibody Therapeutics Market: $39,450M, 21.5% CAGR by 2030
Synopsis
Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.
The global Next Generation Antibody Therapeutics Market [https://www.themarketreports.com/report/global-next-generation-antibody-therapeutics-market-research-report] was valued at US$ 9601 million in 2023 and is anticipated to reach US$ 39450 million by 2030, witnessing a CAGR of 21.5% during the forecast period 2024-2030.
Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 percent.
This report aims to provide a comprehensive presentation of the global market for Next Generation Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Antibody Therapeutics.
Report Scope
The Next Generation Antibody Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Request a Sample Copy or Connect for Further Details: https://www.themarketreports.com/report/ask-your-query/1727369
Market Segmentation
By Company
* Roche
* Amgen
* Pfizer
* Takeda
* Daiichi Sankyo
* Seagen
* Astellas
* Immunomedics
* GSK
* Immunocore
* ADC Therapeutics
Segment by Type
* Antibody Drug Conjugate (ADC)
* Bispecific Antibody (BsAb)
Segment by Application
* Cancer
* Haemophilia
* Other Non-Cancer Diseases
By Region
* North America (United States, Canada and Mexico)
* Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
* Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
* South America (Brazil, Argentina, Colombia, and Rest of South America)
* Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Antibody Therapeutics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Read More Related Research Reports:
Monoclonal Antibody Therapeutics Market: https://www.themarketreports.com/report/global-monoclonal-antibody-therapeutics-market-research-report
Immunoglobulin G Antibody Therapeutics Market: https://www.themarketreports.com/report/global-immunoglobulin-g-antibody-therapeutics-market-research-report
Antibody Therapeutics and Blood Antibody Therapeutics Market: https://www.themarketreports.com/report/global-antibody-therapeutics-and-blood-antibody-therapeutics-market-research-report
About US:
At 'The Market Reports', we are a trusted market research firm dedicated to empowering businesses with valuable insights and data to drive their success. We offer a wide range of comprehensive market research reports to meet the unique needs of each client. From market analysis and competitive intelligence to consumer behaviour and trend forecasting, we provide the critical information necessary to make informed decisions and stay ahead of the competition. Our goal is to empower our clients with the knowledge they need to drive growth, make strategic investments, and seize new opportunities.
Media Contact
Company Name: The Market Reports
Contact Person: Shirish Gupta
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=next-generation-antibody-therapeutics-market-witnessing-a-robust-cagr-of-215-to-reach-us-39450-million-during-the-forecast-period-20242030-the-market-reports]
Phone: +16314071315
Address:SF-29, Sacred World, Wanawadi
City: Pune
State: Maharastra
Country: India
Website: https://www.themarketreports.com/report/global-next-generation-antibody-therapeutics-market-research-report
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Antibody Therapeutics Market Witnessing a Robust CAGR of 21.5%, To Reach US$ 39450 Million During The Forecast Period 2024-2030 | The Market Reports here
News-ID: 3443156 • Views: …
More Releases from ABNewswire
U.S. Robotic Pool Cleaner Market to Surge Past USD 696 Million by 2030, Outperfo …
Florida Leads U.S. with 1.59 Million Residential Pools; California, Texas, Arizona, and Nevada Follow with High Market Potential
With more than 10 million swimming pools across the United States, including 10.4 million residential installations and 6.1 million in-ground pools as of 2025, the country represents one of the world's most robust bases for robotic cleaning technologies. In-ground pools, given their larger dimensions and structural complexity, continue to drive demand for high-performance,…
Wecent Launches New High-Power GaN Charger, Redefining Multi-Device Charging in …
Wecent, a leading manufacturer of GaN and wireless charging solutions [https://www.gdwecent.com/which-is-the-best-gan-charger-for-2025/], today unveiled its newest 100W-240W GaN charger series, designed to deliver ultra-fast, multi-device charging while maintaining compact portability and global safety compliance. The launch underscores Wecent's continued leadership in GaN technology and reinforces its position as a go-to OEM and ODM partner for global brands and distributors.
Next-Generation GaN Technology for Smarter, Faster Charging
The new Wecent chargers integrate advanced Gallium…
Canada Data Center Networking Market Forecast to Reach USD 980 Million by 2030, …
Mordor Intelligence has published a new report on the Canada Data Center Networking Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Canada Data Center Networking Market Overview
The Canada data center networking market [https://www.mordorintelligence.com/industry-reports/canada-data-center-networking-market?utm_source=abnewswire] stands at USD 710 million in 2025 and is forecast to reach USD 980 million by 2030, expanding at a 6.9% CAGR.The market landscape is characterized by a mix of colocation facilities and liquid-cooled…
Team Velocity Named 2025 Microsoft Advertising Channel Partner of the Year
New York, N.Y. - November 19, 2025 - For the second time, Team Velocity [https://teamvelocitymarketing.com/?utm_source=content&utm_medium=paid&utm_campaign=microsoft-awards-press-release-november-2025] has been named Channel Partner of the Year by Microsoft Advertising. This recognition reflects the industry leader's continued success in driving innovation, performance, and collaboration within the Microsoft Advertising ecosystem. Celebrated at the 10th anniversary of the awards in New York City earlier this month, the honor underscores Team Velocity's commitment to delivering best-in-class digital…
More Releases for Antibody
OBP2A Antibody Market Thrives on Technological Innovations in Antibody Productio …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global OBP2A Antibody Market- (By Type (Polyclonal Antibodies, and Monoclonal Antibodies; By Application-(Enzyme Linked Immunosorbent Assay, Immunohistochemistry, & Western Blot)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global OBP2A Antibody Market is valued at US$ 102.9 Mn in 2023, and it is expected to…
Evolving Market Trends In The Antibody Drug Conjugates Industry: Regulation On A …
The Antibody Drug Conjugates Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Antibody Drug Conjugates Market Size During the Forecast Period?
The market size for antibody drug conjugates has experienced rapid expansion in the past few years. It's projected to rise from…
TIGIT Antibody Clinical Trials FDA Approval Market Size Anti TGIT Antibody Sales …
Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028 Report Highlights:
• Anti TIGIT Antibodies In Clinical Trials: > 50 Antibodies
• First Anti TIGIT Antibody To Get Approval Within Next 5 Years
• Global Anti TIGIT Antibodies Clinical Pipeline Insight By Company, Indication and Phase
• Insight On More Than 50 Anti TIGIT Antibodies In Clinical Trials
• Anti TIGIT Antibodies Market Trends by Indication & Country
• Global Anti TIGIT Antibodies Market Dynamics
Download Report:
https://www.kuickresearch.com/report-anti-tigit-antibody-anti-tigit-antibodies-fda-approved-tigit-antibody-tigit-inhibitors-tigit-drugs-approved-tigit-expression-tigit-ligand-tigit-gene
In recent years, the global…
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period."
Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample
Report Overview
Polaris Market Research, a leading global market research and consulting company, has recently published its latest report…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
The combination antibody therapy market is expected to experience significant growth in the coming years. Combination antibody therapy involves the use of two or more monoclonal antibodies (mAbs) in combination to treat various diseases, such as cancer, autoimmune disorders, and infectious diseases.
Request For Free Sample Report of "Combination Antibody Therapy Market"@ https://www.persistencemarketresearch.com/samples/11740
Combination antibody therapy has several potential benefits over single-agent therapies, including increased efficacy, improved patient outcomes, and reduced toxicity.…
Global Combination Antibody Therapy Market 2022: Antibody/Antibody Combination S …
Combination antibody therapy involves the use of two or more antibodies to target and treat a specific disease or condition. This type of therapy is often used in cancer treatment, as it can be more effective at targeting and killing cancer cells than single-antibody therapies. Combination antibody therapy can also be used to treat a range of other diseases and conditions, including autoimmune diseases, infectious diseases, and allergic conditions.
Request For…
